+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Etravirine Market - Global Forecast 2026-2032- Product Image
Etravirine Market - Global Forecast 2026-2032- Product Image
New

Etravirine Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 194 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6015385
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Etravirine Market is evolving rapidly amid significant regulatory, commercial, and supply chain shifts, creating new challenges and opportunities for pharmaceutical stakeholders seeking robust, evidence-led strategic direction. Senior decision-makers need actionable intelligence to drive resilient procurement, competitive positioning, and sustainable market access in this dynamic therapeutic area.

Market Snapshot: Etravirine Market Size, Growth, and Outlook

In recent years, the etravirine market has demonstrated steady growth, expanding from USD 266.59 million in 2025 to USD 281.72 million in 2026. The market is projected to advance at a CAGR of 3.62%, reaching USD 342.04 million by 2032. This upward trend highlights ongoing clinical demand, persistent virologic challenges, and renewed interest in diversified supply strategies.

Scope & Segmentation

This report delivers a granular assessment of the etravirine landscape, encompassing product characteristics, market dynamics, and geographic nuances. The analysis addresses:

  • Dosage Forms: Focus on film-coated tablets, influencing manufacturing scalability, end-user convenience, and packaging preferences.
  • Competition Types: Assessment of branded, authorized generic, and approved generic variants, each presenting distinct market access and pricing implications.
  • Packaging Formats: Detailed evaluation of blister packs, 30-tablet bottles, and 60-tablet bottles considering patient adherence, supply chain durability, and dispensing logistics.
  • End User Settings: Examination of ambulatory care, home care, public clinics, private clinics, public hospitals, and private hospitals, reflecting varied procurement and care delivery models.
  • Distribution Channels: Comparative analysis of hospital pharmacies, retail pharmacies, and online pharmacies, with digital channels bifurcated into mobile app and website-based platforms.
  • Regional Markets: Strategic review of the Americas, Europe, Middle East & Africa, and Asia-Pacific, with each region’s distinct regulatory, reimbursement, and distribution frameworks.

Key Takeaways

  • Clinical positioning of etravirine as a second-generation option is critical for patients with resistance to first-line therapies, offering flexibility in complex treatment regimens.
  • Innovations in resistance profiling and formulation chemistry are influencing both adoption patterns and adherence by supporting personalized, patient-centric dosing options.
  • Health system shifts toward value-based procurement and outcomes-linked contracting are prompting both originators and generics manufacturers to enhance evidence generation and pricing agility.
  • Packaging and distribution strategies increasingly shape access, with trends emphasizing optimized bottle sizes, blister configurations, and multi-channel distribution for improved patient reach and supply stability.
  • Regional differences in regulatory frameworks and payer engagement necessitate locally adapted commercialization and procurement approaches to maintain consistent supply and competitive advantage.
  • Successful strategies depend on integrated supply chain resilience, flexible contracting, and real-world data generation to reinforce etravirine’s value proposition for clinicians, purchasers, and institutions.

Tariff Impact: Supply Chain Adaptations in Response to Regulatory Changes

The 2025 United States tariff regime has significantly altered sourcing and contractual practices in the etravirine supply chain. Manufacturers now emphasize supplier qualification, regionalization, and inventory optimization to counter rising costs and administrative complexities. Procurement strategies increasingly feature risk-sharing and fixed-price agreements, while logistics adjustments and regulatory documentation requirements are reshaping how companies maintain therapeutic continuity under tariff pressures.

Etravirine Market: Methodology & Data Sources

Findings in this report are grounded in a mixed-methods research design incorporating structured stakeholder interviews, systematic regulatory review, and triangulated scenario analysis. Primary input was secured across stakeholder segments—clinical, regulatory, procurement, and commercial—ensuring an authoritative and balanced perspective on market drivers, procurement risks, and product adoption. Internal peer review and document verification strengthen data reliability.

Why This Report Matters

  • Enables decision-makers to anticipate and manage procurement, regulatory, and tariff-driven shocks affecting both branded and generic etravirine products.
  • Supports commercial and operational planning by illuminating actionable insights on dosing strategy, channel engagement, and packaging optimization.
  • Empowers stakeholders with evidence-based guidance for adapting to shifting policy, distribution, and reimbursement environments across key regions.

Conclusion

The etravirine market presents unique opportunities and operational complexities shaped by clinical demand, competitive innovation, and regulatory dynamics. Decision-makers equipped with strategic insights from this report can enhance market access, supply resilience, and product value realization.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Etravirine Market, by Competition Type
8.1. Branded
8.2. Generic
8.2.1. Approved Generic
8.2.2. Authorized Generic
9. Etravirine Market, by Packaging
9.1. Blister Pack
9.2. Bottles
9.2.1. 30 Tablets
9.2.2. 60 Tablets
10. Etravirine Market, by End User
10.1. Ambulatory Care
10.2. Clinics
10.2.1. Private Clinic
10.2.2. Public Clinic
10.3. Home Care
10.4. Hospitals
10.4.1. Private Hospital
10.4.2. Public Hospital
11. Etravirine Market, by Distribution Channel
11.1. Hospital Pharmacy
11.2. Online Pharmacy
11.2.1. Mobile App
11.2.2. Website
11.3. Retail Pharmacy
12. Etravirine Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Etravirine Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Etravirine Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Etravirine Market
16. China Etravirine Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Apotex Pharmachem
17.6. Aurobindo Pharma Limited
17.7. Cipla Limited
17.8. Dr. Reddy’s Laboratories Limited
17.9. Hetero Drugs
17.10. Hetero Healthcare Limited
17.11. HRV Global Life Sciences
17.12. Johnson & Johnson
17.13. Lupin Limited
17.14. MSN Laboratories
17.15. Sandoz International GmbH
17.16. Sun Pharmaceutical Industries Limited
17.17. Teva Pharmaceutical Industries Limited
17.18. Viatris Inc.
List of Figures
FIGURE 1. GLOBAL ETRAVIRINE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ETRAVIRINE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ETRAVIRINE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ETRAVIRINE MARKET SIZE, BY PACKAGING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ETRAVIRINE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ETRAVIRINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ETRAVIRINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ETRAVIRINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES ETRAVIRINE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA ETRAVIRINE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ETRAVIRINE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ETRAVIRINE MARKET SIZE, BY BRANDED, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ETRAVIRINE MARKET SIZE, BY BRANDED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ETRAVIRINE MARKET SIZE, BY BRANDED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ETRAVIRINE MARKET SIZE, BY GENERIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ETRAVIRINE MARKET SIZE, BY GENERIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ETRAVIRINE MARKET SIZE, BY GENERIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ETRAVIRINE MARKET SIZE, BY APPROVED GENERIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ETRAVIRINE MARKET SIZE, BY APPROVED GENERIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ETRAVIRINE MARKET SIZE, BY APPROVED GENERIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ETRAVIRINE MARKET SIZE, BY AUTHORIZED GENERIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ETRAVIRINE MARKET SIZE, BY AUTHORIZED GENERIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ETRAVIRINE MARKET SIZE, BY AUTHORIZED GENERIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ETRAVIRINE MARKET SIZE, BY BLISTER PACK, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ETRAVIRINE MARKET SIZE, BY BLISTER PACK, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ETRAVIRINE MARKET SIZE, BY BLISTER PACK, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ETRAVIRINE MARKET SIZE, BY BOTTLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ETRAVIRINE MARKET SIZE, BY BOTTLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ETRAVIRINE MARKET SIZE, BY BOTTLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ETRAVIRINE MARKET SIZE, BY 30 TABLETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ETRAVIRINE MARKET SIZE, BY 30 TABLETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ETRAVIRINE MARKET SIZE, BY 30 TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ETRAVIRINE MARKET SIZE, BY 60 TABLETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ETRAVIRINE MARKET SIZE, BY 60 TABLETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ETRAVIRINE MARKET SIZE, BY 60 TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ETRAVIRINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ETRAVIRINE MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ETRAVIRINE MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ETRAVIRINE MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ETRAVIRINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ETRAVIRINE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ETRAVIRINE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ETRAVIRINE MARKET SIZE, BY PRIVATE CLINIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ETRAVIRINE MARKET SIZE, BY PRIVATE CLINIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ETRAVIRINE MARKET SIZE, BY PRIVATE CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ETRAVIRINE MARKET SIZE, BY PUBLIC CLINIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ETRAVIRINE MARKET SIZE, BY PUBLIC CLINIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ETRAVIRINE MARKET SIZE, BY PUBLIC CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ETRAVIRINE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ETRAVIRINE MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ETRAVIRINE MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ETRAVIRINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ETRAVIRINE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ETRAVIRINE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ETRAVIRINE MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ETRAVIRINE MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ETRAVIRINE MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ETRAVIRINE MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ETRAVIRINE MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ETRAVIRINE MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ETRAVIRINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ETRAVIRINE MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ETRAVIRINE MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ETRAVIRINE MARKET SIZE, BY MOBILE APP, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ETRAVIRINE MARKET SIZE, BY MOBILE APP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ETRAVIRINE MARKET SIZE, BY MOBILE APP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ETRAVIRINE MARKET SIZE, BY WEBSITE, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ETRAVIRINE MARKET SIZE, BY WEBSITE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ETRAVIRINE MARKET SIZE, BY WEBSITE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ETRAVIRINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ETRAVIRINE MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ETRAVIRINE MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ETRAVIRINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. AMERICAS ETRAVIRINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS ETRAVIRINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 82. AMERICAS ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA ETRAVIRINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. NORTH AMERICA ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA ETRAVIRINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA ETRAVIRINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2032 (USD MILLION)
TABLE 97. LATIN AMERICA ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
TABLE 100. LATIN AMERICA ETRAVIRINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2032 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 115. EUROPE ETRAVIRINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. EUROPE ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2032 (USD MILLION)
TABLE 117. EUROPE ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 118. EUROPE ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 119. EUROPE ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
TABLE 120. EUROPE ETRAVIRINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 121. EUROPE ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 122. EUROPE ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 123. EUROPE ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 124. EUROPE ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 125. MIDDLE EAST ETRAVIRINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. MIDDLE EAST ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2032 (USD MILLION)
TABLE 127. MIDDLE EAST ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 128. MIDDLE EAST ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 129. MIDDLE EAST ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
TABLE 130. MIDDLE EAST ETRAVIRINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 132. MIDDLE EAST ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 133. MIDDLE EAST ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 135. AFRICA ETRAVIRINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. AFRICA ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2032 (USD MILLION)
TABLE 137. AFRICA ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 138. AFRICA ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 139. AFRICA ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
TABLE 140. AFRICA ETRAVIRINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 141. AFRICA ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 142. AFRICA ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 143. AFRICA ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 144. AFRICA ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC ETRAVIRINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC ETRAVIRINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL ETRAVIRINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 156. ASEAN ETRAVIRINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. ASEAN ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2032 (USD MILLION)
TABLE 158. ASEAN ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 159. ASEAN ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 160. ASEAN ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
TABLE 161. ASEAN ETRAVIRINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 162. ASEAN ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 163. ASEAN ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 164. ASEAN ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 165. ASEAN ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 166. GCC ETRAVIRINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 167. GCC ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2032 (USD MILLION)
TABLE 168. GCC ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 169. GCC ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 170. GCC ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
TABLE 171. GCC ETRAVIRINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 172. GCC ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 173. GCC ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 174. GCC ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 175. GCC ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 176. EUROPEAN UNION ETRAVIRINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. EUROPEAN UNION ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2032 (USD MILLION)
TABLE 178. EUROPEAN UNION ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 179. EUROPEAN UNION ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION ETRAVIRINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 186. BRICS ETRAVIRINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. BRICS ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2032 (USD MILLION)
TABLE 188. BRICS ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 189. BRICS ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 190. BRICS ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
TABLE 191. BRICS ETRAVIRINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 192. BRICS ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 193. BRICS ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 194. BRICS ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 195. BRICS ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 196. G7 ETRAVIRINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 197. G7 ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2032 (USD MILLION)
TABLE 198. G7 ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 199. G7 ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 200. G7 ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
TABLE 201. G7 ETRAVIRINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 202. G7 ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 203. G7 ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 204. G7 ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 205. G7 ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 206. NATO ETRAVIRINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 207. NATO ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2032 (USD MILLION)
TABLE 208. NATO ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 209. NATO ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 210. NATO ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
TABLE 211. NATO ETRAVIRINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 212. NATO ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 213. NATO ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 214. NATO ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 215. NATO ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 216. GLOBAL ETRAVIRINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. UNITED STATES ETRAVIRINE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 218. UNITED STATES ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2032 (USD MILLION)
TABLE 219. UNITED STATES ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 220. UNITED STATES ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 221. UNITED STATES ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
TABLE 222. UNITED STATES ETRAVIRINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 223. UNITED STATES ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 224. UNITED STATES ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 225. UNITED STATES ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 226. UNITED STATES ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 227. CHINA ETRAVIRINE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 228. CHINA ETRAVIRINE MARKET SIZE, BY COMPETITION TYPE, 2018-2032 (USD MILLION)
TABLE 229. CHINA ETRAVIRINE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 230. CHINA ETRAVIRINE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
TABLE 231. CHINA ETRAVIRINE MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
TABLE 232. CHINA ETRAVIRINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 233. CHINA ETRAVIRINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 234. CHINA ETRAVIRINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 235. CHINA ETRAVIRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 236. CHINA ETRAVIRINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)

Companies Mentioned

  • Apotex Pharmachem
  • Aurobindo Pharma Limited
  • Cipla Limited
  • Dr. Reddy’s Laboratories Limited
  • Hetero Drugs
  • Hetero Healthcare Limited
  • HRV Global Life Sciences
  • Johnson & Johnson
  • Lupin Limited
  • MSN Laboratories
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Limited
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages194
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 281.72 Million
Forecasted Market Value ( USD ) by 2032 $ 342.04 Million
Compound Annual Growth Rate3.6%
Regions CoveredGlobal
No. of Companies Mentioned14

Related Topics

Related Reports

Etravirine (CAS 269055-15-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Etravirine (CAS 269055-15-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
HIV Clinical Trials Market - Global Forecast 2026-2032 - Product Image

HIV Clinical Trials Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Human Immunodeficiency Virus Therapeutics Market - Global Forecast 2026-2032 - Product Image

Human Immunodeficiency Virus Therapeutics Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
HIV Drugs Market Report 2025 - Product Image

HIV Drugs Market Report 2025

  • Report
  • 250 Pages
  • Global
From
HIV Drugs Market Size Analysis Report - Market Share, Forecast Trends and Outlook 2025-2034 - Product Image

HIV Drugs Market Size Analysis Report - Market Share, Forecast Trends and Outlook 2025-2034

  • Report
  • 350 Pages
  • Global
From

About the Etravirine Market

Etravirine is an antiretroviral drug used to treat HIV/AIDS. It is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that works by blocking the action of the HIV-1 reverse transcriptase enzyme, which is responsible for the replication of the virus. Etravirine is used in combination with other antiretroviral drugs to treat HIV-1 infection in adults and adolescents over the age of 12. It is also used to treat HIV-1 infection in adults and adolescents over the age of 12 who have already been treated with other antiretroviral drugs. Etravirine is available in tablet form and is taken orally. It is usually taken twice daily with food. Common side effects of etravirine include nausea, headache, and dizziness. More serious side effects may include liver problems, changes in body fat, and changes in the immune system. Etravirine is marketed by several pharmaceutical companies, including Janssen Pharmaceuticals, Merck & Co., and Tibotec Pharmaceuticals. It is also available in generic form from several generic drug manufacturers. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.